Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Laser Therapy and Clonazepam in Burning Mouth Syndrome
NCT06217731Completed
- Sponsor
- Universidad de Murcia
- Start
- Jan 2022
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of clonazepam in burning mouth syndrome (BMS) (4 arms), sponsored by Universidad de Murcia. Primary endpoint: Pain Visual Analogue Scale at 1 month. Started Jan 2022; status: completed.
02
Drugs
clonazepam
03
Conditions
burning mouth syndrome (BMS)
Beyond the preview
Go deeper on NCT06217731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06217731.